DAVID EMERSON JORDEN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID EMERSON JORDEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID EMERSON JORDEN. DAVID EMERSON JORDEN is a Acting Chief Financial Officer in Opexa Therapeutics, Inc. ($OPXA) and a Director in Opexa Therapeutics, Inc. ($OPXA).
Address: C/O OPEXA THERAPEUTICS, INC. 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS 77381 TX
Companies in which DAVID EMERSON JORDEN is an Insider
Acer Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID EMERSON JORDEN: Acting Chief Financial Officer, Director
Holdings: 293,456 shares
Current Value: $299,325
Latest Transaction: Sep 26 2013
$ACER Market Capitalization: $7.21M
$ACER Previous Close: $1.02
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DAVID EMERSON JORDEN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 26 2013 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Buy | C | 1.91 | 61,912 | 118,252 | 293,456 | 231.5 K to 293.5 K (+26.74 %) |
| Jul 02 2013 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Grant | A | 1.54 | 4,450 | 6,853 | 231,544 | 227.1 K to 231.5 K (+1.96 %) |
| May 01 2013 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 1.75 | 17,143 | 30,000 | 17,143 | |
| May 01 2013 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 1.75 | 5,000 | 8,750 | 5,000 | |
| Jan 31 2013 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Acting Chief Financ ... | Option Exercise | A | 1.21 | 5,278 | 6,386 | 5,278 | |
| Jan 24 2013 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Acting Chief Financ ... | Option Exercise | A | 1.24 | 37,500 | 46,500 | 37,500 | |
| Jan 24 2013 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Acting Chief Financ ... | Grant | A | 1.33 | 4,595 | 6,111 | 227,094 | 222.5 K to 227.1 K (+2.07 %) |